PT

Priyanka Tuli

Director Director DIN 01553882
DIN 01553882 First appointment Jun 2007 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2007
Shareholding value Locked Premium profile

About Priyanka Tuli

Data last updated:

Priyanka Tuli has 19 years in corporate governance. Formerly with 1 company, such as Rejis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01553882
Primary Designation Director
First Appointment 29 Jun 2007
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Rejis Pharma Private Limited U24233DL2007PTC165307
Director29 Jun 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rejis Pharma Private Limited
Premium access

Shareholding and investment profile for Priyanka Tuli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Tuli

Priyanka Tuli has 19 years in corporate governance. Formerly with 1 company, such as Rejis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Priyanka Tuli is associated with 0 companies as a director.

Priyanka Tuli has expertise in General Business.

Priyanka Tuli has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available